BG38164A3 - Method for preparing n- substanced- 4- piperidanoamides - Google Patents

Method for preparing n- substanced- 4- piperidanoamides

Info

Publication number
BG38164A3
BG38164A3 BG7943114A BG4311479A BG38164A3 BG 38164 A3 BG38164 A3 BG 38164A3 BG 7943114 A BG7943114 A BG 7943114A BG 4311479 A BG4311479 A BG 4311479A BG 38164 A3 BG38164 A3 BG 38164A3
Authority
BG
Bulgaria
Prior art keywords
piperidanoamides
substanced
preparing
Prior art date
Application number
BG7943114A
Other languages
English (en)
Inventor
Janssens
Stokbroekx
Tprremans
Original Assignee
Janssen Pharmaceutica Nv,Be
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26670178&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG38164(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US06/002,276 external-priority patent/US4219559A/en
Application filed by Janssen Pharmaceutica Nv,Be filed Critical Janssen Pharmaceutica Nv,Be
Publication of BG38164A3 publication Critical patent/BG38164A3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/54—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
BG7943114A 1978-04-03 1979-04-03 Method for preparing n- substanced- 4- piperidanoamides BG38164A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US89253478A 1978-04-03 1978-04-03
US06/002,276 US4219559A (en) 1979-01-10 1979-01-10 N-Heterocyclyl-4-piperidinamines

Publications (1)

Publication Number Publication Date
BG38164A3 true BG38164A3 (en) 1985-10-15

Family

ID=26670178

Family Applications (1)

Application Number Title Priority Date Filing Date
BG7943114A BG38164A3 (en) 1978-04-03 1979-04-03 Method for preparing n- substanced- 4- piperidanoamides

Country Status (29)

Country Link
EP (1) EP0005318B1 (ro)
JP (2) JPS54151982A (ro)
AT (1) AT373887B (ro)
AU (1) AU523352B2 (ro)
BG (1) BG38164A3 (ro)
CA (1) CA1140119A (ro)
CS (1) CS256358B2 (ro)
CY (1) CY1250A (ro)
DE (1) DE2961740D1 (ro)
DK (1) DK169325B1 (ro)
EG (1) EG13913A (ro)
ES (1) ES479206A1 (ro)
FI (1) FI64801C (ro)
GR (1) GR64907B (ro)
HK (1) HK3184A (ro)
HU (1) HU182965B (ro)
IE (1) IE47818B1 (ro)
IL (1) IL56992A (ro)
MY (1) MY8500046A (ro)
NO (2) NO154058C (ro)
NZ (1) NZ189978A (ro)
PH (1) PH15877A (ro)
PL (1) PL123380B1 (ro)
PT (1) PT69429A (ro)
RO (1) RO79320A (ro)
SG (1) SG29883G (ro)
SU (1) SU1056902A3 (ro)
YU (2) YU42484B (ro)
ZA (1) ZA791557B (ro)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA19091A1 (fr) * 1980-03-10 1981-10-01 Janssen Pharmaceutica Nv Nouveaux derives de i-(4-aryl-cyclohexyl)piperidine .
US4556660A (en) * 1982-07-12 1985-12-03 Janssen Pharmaceutica N.V. N-(Bicyclic heterocyclyl)-4-piperidinamines
IN156065B (ro) * 1982-07-12 1985-05-04 Janssen Pharmaceutica Nv
US4634704A (en) * 1983-10-06 1987-01-06 Janssen Pharmaceutica, N.V. Anti-allergic five membered heterocyclic ring containing N-(bicyclic heterocycyl)-4-piperidinamines
DE3484096D1 (de) * 1983-11-30 1991-03-14 Janssen Pharmaceutica Nv Bizyklisches heterozyklyl aufveisende n-(bizyklisches heterozyklyl-4-piperidinamine.
PL144514B1 (en) * 1984-01-09 1988-06-30 Janssen Pharmaceutica Nv Method of obtaining novel derivatives of n-/4-piperidinolo/-2-imidazoloamine
KR930005004B1 (ko) * 1985-04-15 1993-06-11 쟈안센 파아마슈우티카 엔. 부이. 치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법
GB8515934D0 (en) * 1985-06-24 1985-07-24 Janssen Pharmaceutica Nv (4-piperidinomethyl and-hetero)purines
DE3781173T2 (de) * 1986-02-03 1992-12-17 Janssen Pharmaceutica Nv N-heterozyklische-4-piperidinamine enthaltende anti-histaminische zusammensetzungen.
NZ223654A (en) * 1987-03-09 1990-03-27 Janssen Pharmaceutica Nv 1-alkyl-substituted-benzimidazole-4-piperidinamines and pharmaceutical compositions
FR2618435B1 (fr) * 1987-07-23 1989-10-27 Synthelabo Derives de benzimidazole, leur preparation et leur application en therapeutique
US5210091A (en) * 1991-06-24 1993-05-11 Neurosearch A/S Imidazole compounds and their use
WO1994027973A1 (fr) * 1993-05-20 1994-12-08 Kissei Pharmaceutical Co., Ltd. Derive 1-(2-benzimidazolyl)-1,5-diazacyclooctane
US5547966A (en) * 1993-10-07 1996-08-20 Bristol-Myers Squibb Company Aryl urea and related compounds
PL343435A1 (en) * 1998-03-06 2001-08-13 Janssen Pharmaceutica Nv Glycine transport inhibitors
EP1196409B1 (en) * 1999-06-28 2004-02-04 Janssen Pharmaceutica N.V. Respiratory syncytial virus replication inhibitors
AU779516B2 (en) * 1999-06-28 2005-01-27 Janssen Pharmaceutica N.V. Respiratory syncytial virus replication inhibitors
IL147328A0 (en) * 1999-06-28 2002-08-14 Janssen Pharmaceutica Nv Respiratory syncytial virus replication inhibitors
ES2278729T3 (es) 2000-03-06 2007-08-16 Acadia Pharmaceuticals Inc. Compuestos azaciclicos para usar en el tratamiento de enfermedades relacionadas con la serotonina.
CN100347167C (zh) 2001-02-02 2007-11-07 特瓦制药工业有限公司 取代的2－(2－吡啶基甲基)亚磺酰基－1h－苯并咪唑化合物的生产方法
WO2003057698A2 (en) 2001-12-28 2003-07-17 Acadia Pharmaceuticals, Inc. Spiroazacyclic compounds as monoamine receptor modulators
EP2266590A3 (en) 2002-02-22 2011-04-20 Shire LLC Active agent delivery sytems and methods for protecting and administering active agents
US7253186B2 (en) 2002-06-24 2007-08-07 Carl-Magnus Andersson N-substituted piperidine derivatives as serotonin receptor agents
RU2320646C2 (ru) 2002-06-24 2008-03-27 Акадиа Фармасьютикалз Инк. N-замещенные производные пиперидина в качестве агентов серотонинового рецептора
US7538222B2 (en) 2002-06-24 2009-05-26 Acadia Pharmaceuticals, Inc. N-substituted piperidine derivatives as serotonin receptor agents
CN101780080B (zh) 2003-01-16 2014-06-04 阿卡蒂亚药品公司 用于神经退行性疾病的治疗的选择性五羟色胺2a/2c受体反向激动剂
DE602004031555D1 (de) 2003-12-18 2011-04-07 Little Island Co Cork 5- oder 6-substituierte benzimidazolderivate als inhibitoren der replikation des respiratory syncytial virus
CN1894239A (zh) 2003-12-18 2007-01-10 泰博特克药品有限公司 作为呼吸道合胞病毒复制的抑制剂的哌啶－氨基－苯并咪唑类衍生物
RU2379302C2 (ru) 2003-12-18 2010-01-20 Тиботек Фармасьютикалз Лтд. Аминобензимидазолы и бензимидазолы в качестве ингибиторов репликации респираторно-синцитиального вируса
US20050261278A1 (en) 2004-05-21 2005-11-24 Weiner David M Selective serotonin receptor inverse agonists as therapeutics for disease
US7820695B2 (en) 2004-05-21 2010-10-26 Acadia Pharmaceuticals, Inc. Selective serotonin receptor inverse agonists as therapeutics for disease
US7790899B2 (en) 2004-09-27 2010-09-07 Acadia Pharmaceuticals, Inc. Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms
NZ553702A (en) 2004-09-27 2010-10-29 Acadia Pharm Inc Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms
CN101677971A (zh) 2007-03-19 2010-03-24 阿卡蒂亚药品公司 5-ht2a反向激动剂和拮抗剂与抗精神病药物的组合
CA2992728A1 (en) 2015-07-20 2017-01-26 Acadia Pharmaceuticals Inc. Methods for preparing n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and polymorphic form c
US10953000B2 (en) 2016-03-25 2021-03-23 Acadia Pharmaceuticals Inc. Combination of pimavanserin and cytochrome P450 modulators
WO2017165635A1 (en) 2016-03-25 2017-09-28 Acadia Pharmaceuticals Inc. Combination of pimavanserin and cytochrome p450 modulators
WO2018118626A1 (en) 2016-12-20 2018-06-28 Acadia Pharmaceuticals Inc. Pimavanserin alone or in combination for use in the treatment of alzheimer's disease psychosis
US11135211B2 (en) 2017-04-28 2021-10-05 Acadia Pharmaceuticals Inc. Pimavanserin for treating impulse control disorder
WO2019046167A1 (en) 2017-08-30 2019-03-07 Acadia Pharmaceuticals Inc. PIMAVANSERIN FORMULATIONS

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2857391A (en) * 1955-04-15 1958-10-21 Merck & Co Inc Aminomethylbenzimidazoles
US2971005A (en) * 1958-10-17 1961-02-07 Merck & Co Inc Nu-substituted derivatives of 2-benzylaminobenzimidazoles
BE788065A (fr) * 1971-08-26 1973-02-26 Degussa Nouvelles aza-benzimidazoles et procede pour leur preparation

Also Published As

Publication number Publication date
IE47818B1 (en) 1984-06-27
CY1250A (en) 1984-08-31
AU4529679A (en) 1979-10-18
HU182965B (en) 1984-03-28
DK129879A (da) 1979-10-04
CS222779A2 (en) 1987-03-12
FI64801B (fi) 1983-09-30
FI64801C (fi) 1984-01-10
EG13913A (en) 1982-09-30
NO154090C (no) 1986-07-16
ES479206A1 (es) 1979-12-16
NO154058B (no) 1986-04-01
PT69429A (pt) 1979-05-01
AU523352B2 (en) 1982-07-22
AT373887B (de) 1984-02-27
DK169325B1 (da) 1994-10-10
NO154058C (no) 1986-07-09
HK3184A (en) 1984-01-20
IE790676L (en) 1979-10-03
EP0005318B1 (en) 1982-01-06
CA1140119A (en) 1983-01-25
FI791084A (fi) 1979-10-04
GR64907B (en) 1980-06-07
JPS54151982A (en) 1979-11-29
DE2961740D1 (en) 1982-02-25
EP0005318A1 (en) 1979-11-14
IL56992A0 (en) 1979-07-25
YU43158B (en) 1989-04-30
NO842563L (no) 1979-10-04
PL214648A1 (ro) 1980-03-24
JPS641477B2 (ro) 1989-01-11
NO791097L (no) 1979-10-04
PH15877A (en) 1983-04-13
NZ189978A (en) 1984-05-31
YU78479A (en) 1983-10-31
IL56992A (en) 1983-03-31
PL123380B1 (en) 1982-10-30
ZA791557B (en) 1980-11-26
YU42484B (en) 1988-10-31
MY8500046A (en) 1985-12-31
JPH0240666B2 (ro) 1990-09-12
SU1056902A3 (ru) 1983-11-23
SG29883G (en) 1984-04-19
RO79320A (ro) 1982-08-17
ATA242579A (de) 1983-07-15
NO154090B (no) 1986-04-07
CS256358B2 (en) 1988-04-15
YU50283A (en) 1983-12-31
JPH01117880A (ja) 1989-05-10

Similar Documents

Publication Publication Date Title
BG40654A3 (en) Method for preparing cycloalkyltriazoles
BG38164A3 (en) Method for preparing n- substanced- 4- piperidanoamides
YU170479A (en) Process for preparing 2-chloro-6-nitroanilines
BG40480A3 (en) Method for preparing phenetanolamines
GB2018816B (en) Process for preparing hexamethyltetrahydronaphthalenes
BG31492A3 (en) Method for obtaining phenetanolamines
PT70313A (en) Process for preparing substituted 1-thia-3-aza-4-ones
BG35033A3 (en) Method for preparing o- metalyloxyphenol
GB2034701B (en) Process for preparing 2-chlorosulphinylazetidinones
GB2019835B (en) Process for preparing n-carbamoyl-d-thienylglycines
DE2961058D1 (en) Process for preparing alpha-chloro-n-monoalkyl-acetoacetamides
DE2960047D1 (en) Process for preparing 2-oximinophenylacetonitrile
YU41093B (en) Process for preparing 6-deoxy-5hydroxy-tetracycline
GB2013180B (en) Process for preparing n ethylethylenediamine
BG40315A3 (en) Method for preparing auronic derivatives
YU40533B (en) Process for preparing 2-bromoergosinine
DE2964629D1 (en) Process for preparing 3-amino-5-t-butylisoxazole
DE2963897D1 (en) Process for preparing sodium-m-nitrobenzenesulfonate
PT67655A (en) Method for preparing cyano-alquyl-guanidines
PT69908A (en) Process for preparing cis-bicyclooctylamines
PT69287A (en) Process for preparing benzocycloheptapyrans
GB2025414B (en) Process for preparing cis-bicyclooctylamines
BG40479A3 (en) Method for preparing phenylethyr compounds
BG29479A1 (en) Method for 9- bensylharmine obtaining
MW3079A1 (en) Process for preparing 2-chlorosulfinylazetidinones